Unusual respiratory bacterial flora in cystic fibrosis: Microbiologic and clinical features

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 6, 2000, Pages 545-550

  Beringer, P M ^a   Appleman, M D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CHLORAMPHENICOL; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; IMIPENEM; LINEZOLID; METICILLIN; MINOCYCLINE; OXACILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ALCALIGENES; ANTIBIOTIC SENSITIVITY; BACTERIAL FLORA; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; CYSTIC FIBROSIS; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RALSTONIA; RESPIRATORY TRACT INFECTION; REVIEW; STENOTROPHOMONAS MALTOPHILIA;

EID: 0033779760     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200011000-00015     Document Type: Review

References (41)

1. The innate immune system in cystic fibrosis lung disease
2. 1 and treatment intensity during Pseudomonas aeruginosa colonization in patients with cystic fibrosis
3. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis
4. Microbiology of sputum from patients at cystic fibrosis centers in the United States
5. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis
6. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV)
7. Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods
8. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
9. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR
10. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis
11. Burkholderia cepacia: Management issues and new insights
12. Outcome for patients colonized with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic at the end of an epidemic
13. Burkholderia cepacia in cystic fibrosis: Variable disease course
14. Infections in patients with cystic fibrosis following lung transplantation
15. Burkholderia cepacia infections in cystic fibrosis
16. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis
17. Evaluation of three oligonucleotide primers sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli
18. Species-specific PCR as a tool for the identification of Burkholderia gladioli
19. Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR
20. Four additional cases of Burkholderia gladioli infection with microbiological correlates and review
21. CDC Group IV c-2: A new Ralstonia species close to Ralstonia eutropha
22. Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia
23. Stenotrophomonas maltophilia in cystic fibrosis patients
24. Stenotrophomonas maltophilia in cystic fibrosis: Incidence and prevalence
25. Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system
26. A new approach to the treatment of Xanthomonas maltophilia respiratory infection in a patient with cystic fibrosis
27. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: A retrospective clinical study conducted by means of molecular epidemiological investigation
28. Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: Use of repetitive-element-sequence polymerase chain reaction
29. Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis
30. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management
31. Detection of oxacillin-resistance in Staphylococcus aureus by MicroScan MIC panels in comparison to four other methods
32. Misclassification of susceptible strains of Staphylococcus aureus as methicillin-resistant S. aureus by a rapid automated susceptibility testing system
33. Evaluation of MRSA-screen, a simple antiPBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus
34. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit
35. MRSA in cystic fibrosis
36. Methicillin-resistant Staphylococcus aureus: Impact at a national cystic fibrosis centre